Univdatos Whatsapp

Increasing cases of cardiovascular disease and sepsis is likely to propel the demand of immunoadsorption devices

The global immunoadsorption devices market is expected to showcase robust growth during the forecast period (2021-2027). Globally, rising number of cardiovascular disease cases is likely to increase the demand of immunoadsorption devices market. In cardiology, the device is commonly use in dilated cardiomyopathy, myocardial infarction, chagas cardiomyopathy, and hyperlipidemia. Further, with the increasing use of immunoadsorption device in the treatment of sepsis or sepsis shock is likely to further boost the market. According to the Centers for Disease Control and Prevention (CDC), at least 1.7 million adults in the United States develop sepsis, and nearly 270,000 dies as a result.

Rising number of cases related to cardiology, neurology, dermatology, kidney, and transplant owing to changing people lifestyle, growing geriatric population, and pollution is boosting the demand of immunoadsorption devices. These devices are used in disease such as dilated cardiomyopathy, myocardial infarction, chagas cardiomyopathy, hyperlipidemia, multiple sclerosis, Guillain-Barre syndrome, autoimmune encephalitis, chronic inflammatory demyelinating polyradiculopathy, dementia, Lambert-Eaton myasthenic syndrome. Further, with the advancement in the sector, the immunoadsorption device is finding new application areas such as sepsis.

For a detailed analysis of the global immunoadsorption devices market browse throughhttps://univdatos.com/report/immunoadsorption-devices-market/

Immunoadsorption is an extracorporeal technique used for the removal of specific blood group antibodies and molecules from the blood. Currently, a large and different number of devices or columns each with a different active component to which the molecule of interest attaches, thereby allowing for selectivity in the molecules removed. The ability to select a different type of device for different conditions makes the immunoadsorption’s significant advantages over other apheresis techniques, in that it negates the need for replacement of factors such as albumin and plasma. For instance, Pocard’s Toxipak is a selective immunoadsorption device used in sepsis and sepsis shock where another selective immunoadsorption device Gylcosorb ABO is used in ABO compatibility.

Based on product, the market is categorized into Toxipak, Pentrasorb CRP, Glycosorb ABO, IgEnio, DALI, Monet, Immunsorba TR, Immunsorba, Therasorb, Selesorb, Oxiris, Cytosorb, Toraymyxin, Seraph, Alteco LPS Adsorber, and others. Each device has its unique properties, some are selective immunoadsorption devices while others are non-selective, semi-selective, or other types of devices. However, the basic function of all the device is the same, to remove the specific blood group antibodies and molecules from the blood.

Based on type, the market is categorized into selective, semi-selective, non-selective, and others. Among these, selective category held the considerable market share and is expected to continue its performance during the forecast period. This can be attributed to the presence of large number of immunoadsorption devices like Toxipak, Pentrasorb CRP, Miro, Glycosorb ABO, ABO Adsopak, Coraffin, IgEnio, DALI, Monet, and LDL lipopak. Further, selective immunoadsorption device helps in selectively target the molecules without disturbing other molecules, thereby it is commonly used in autoimmune conditions and transplantation

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=18787

For a better understanding of the market adoption of Immunoadsorption Devices, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America accounted for significant share in the market and is expected to showcase substantial growth during the forecast period owing developed healthcare infrastructure, large expenditure in the healthcare industry couple with adoption of new technologies in the region.

Global Immunoadsorption Devices Market Segmentation

Market Insight, by Type

  • Selective
  • Semi-Selective
  • Non-Selective
  • Others

Market Insight, by Product

  • Toxipak
  • Pentrasorb CRP
  • Glycosorb ABO
  • IgEnio
  • DALI
  • MONET
  • Immunsorba TR
  • Immunsorba
  • Therasorb
  • Selesorb
  • Oxiris
  • Cytosorb
  • Toraymyxin
  • Seraph
  • Alteco LPS Adsorber
  • Others

Market Insight, by Therapeutic Area

  • Cardiology
  • Neurology
  • Transplant
  • Kidney
  • Others

Market Insight, by Region

  • North America Immunoadsorption Devices Market
    • United States
    • Canada
    • Rest of North America
  • Europe Immunoadsorption Devices Market
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific Immunoadsorption Devices Market
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of World Immunoadsorption Devices Market

Top Company Profiles

  • Pocard Ltd.
  • Pentracor GmbH
  • Glycorex Transplantation AB
  • Fresenius Medical Care
  • Asahi Kasei Medical Device
  • Miltenyi Biotec
  • Kaneka Medical Product
  • Baxter International Inc.
  • CytoSorbents Europe GmbH
  • Toray Medical Co. Ltd.

Leave A Comment

Select Language